Evidence map›Paper›PMID 41979118›Full record

ArticleThoracic research and practice2026

The Impact of the Exposome on Epithelial Barriers: New Approach Methodologies for Translational Research.

Pelin Saglam-Metiner, Ebru Calkan-Yildirim, Basar Dogan, R Dilara Vaizoglu, Cigdem Elif Celik, Ozlem Goksel, Ozlem Yesil-Celiktas, Levent Pelit, Yasin Kaymaz, Henrik Kløverpris and 6 more

Abstract read
In one paragraph

Article in Thoracic research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Pelin Saglam-MetinerTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0002-5726-1928
Ebru Calkan-YildirimTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0003-0530-3388
Basar DoganTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0009-0008-1680-283X
R Dilara VaizogluTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0003-4584-0954
Cigdem Elif CelikTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0002-8542-9791
Ozlem GokselTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0003-1121-9967
Ozlem Yesil-CeliktasTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0003-4509-2212
Levent PelitTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0001-8090-703X
Yasin KaymazTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0002-9725-7536
Henrik KløverprisDepartment of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-2165-3313
Douglas S KwonRagon Institute of Mass General Brigham, Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.ORCID 0000-0001-8521-8735
Carla F KimStem Cell Program, Division of Hematology, Oncology and Pulmonary, Respiratory Diseases, Department of Pediatrics, Boston Children's Hospital, Massachusetts, USA.ORCID 0000-0002-2366-9538
Petros KoutrakisDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-1735-0608
Cezmi AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID 0000-0001-8020-019X
Omer H YilmazDepartment of Biology, The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0002-7577-4612
Tuncay GokselTranslational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye.ORCID 0000-0002-6089-1840

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental exposures experienced throughout life, collectively referred to as the exposome, play a fundamental role in shaping epithelial barrier integrity, repair capacity, and vulnerability to disease. These exposures encompass a broad spectrum of chemical, physical, biological, and lifestyle-related factors. Despite growing recognition of their importance, a key unresolved challenge is understanding how single exposures and, more importantly, complex real-world exposure mixtures jointly disrupt epithelial organization, stem and progenitor cell niches, and immune-epithelial communication across different organs. This review consolidates current evidence on environmentally relevant exposomes that directly affect epithelial barrier function and examines their consequences for tissue architecture, niche stability, and frontline defense mechanisms. We further discuss recent advances in new approach methodologies, including organ-specific epithelial barrier models, organoids, organ-on-a-chips, and interconnected multi-organ platforms. By synthesizing evidence across organ systems, we highlight convergent biological processes, such as oxidative stress, inflammatory signaling, disruption of intercellular junctions, and impaired epithelial survival or regeneration, as shared pathways linking environmental stressors to barrier failure. We hope that this review will help bridge exposure science, epithelial biology, and bioengineered human-based models to define critical knowledge gaps and key translational priorities for the field.

Indexed as

environmental exposomeEpithelial barrierNAMsorgan-axis models

Identifiers

PMID41979118
PMCPMC13162292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.